Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride MeSH Descriptor Data 2025


MeSH Heading
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride
Tree Number(s)
D02.092.877.674.033
D02.455.326.397.325
D02.675.276.210
Unique ID
D008455
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D008455
Annotation
McN stands for McNeil (a pharmaceut co)
Scope Note
A drug that selectively activates certain subclasses of muscarinic receptors and also activates postganglionic nicotinic receptors. It is commonly used experimentally to distinguish muscarinic receptor subtypes.
Entry Term(s)
McN A-343
McN-A-343
McN-A343
McNeil A 343
Pharm Action
Ganglionic Stimulants
Muscarinic Agonists
Nicotinic Agonists
Registry Numbers
55-45-8
0
CAS Type 1 Name
2-Butyn-1-aminium, 4-((((3-chlorophenyl)amino)carbonyl)oxy)-N,N,N-trimethyl-, chloride
Previous Indexing
Alkynes (1972-1974)
Ammonium Compounds (1968-1974)
Carbamates (1968-1974)
Public MeSH Note
2005; see McN-A-343 1991-2004; see AMMONIUM COMPOUNDS 1975-1990
History Note
2005(1975)
Date Established
1991/01/01
Date of Entry
1974/11/19
Revision Date
2016/06/28
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride Preferred
McN-A-343 Narrower
page delivered in 0.139s